Medical Clinic Operator signs lease to open new Edmonton Clinic
OTTAWA, Nov. 17, 2017 /CNW/ - National Access Cannabis Corp. ("NAC" or the "Company") (TSX VENTURE: NAC), Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis, today announced that it has expanded its Alberta operations with the signing of a lease for a new care clinic in Edmonton's Old Strathcona District.
National Access Cannabis's latest clinic will be located at the highly visible corner of Whyte Avenue and Calgary Trail. Construction is set to begin immediately and the Company expects the grand opening of the new facility to occur in January 2018.
"NAC is committed to delivering secure, safe, and responsible access to legal cannabis and we're pleased to expand our trusted clinic model to the residents of Edmonton," said Mark Goliger, Chief Executive Officer of National Access Cannabis. "With traffic volumes of greater than 40,000 vehicles a day, our new Whyte Avenue location represents a prime location for a medical cannabis clinic as well as for a future, legal, licensed, retail dispensary under the proposed Alberta framework. Growing beyond our existing four care clinics in Calgary and providing Albertans with improved access to physicians and education through additional regional facilities across Alberta reflects our commitment to be the leader in Alberta's evolving medical and recreational cannabis market."
The new clinic includes approximately 2,100 square feet of space designated to the consultation of patients receiving or inquiring about cannabinoid therapy. National Access Cannabis' cannabinoid specialists will consult with patients exploring the options available through health Canada approved licensed producers. Clinical staff work in tandem with physicians to provide safe and effective medical cannabis protocols.
About National Access Cannabis
National Access Cannabis is Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis. NAC enables patients to gain knowledge and the legal medical documentation required to navigate Canada's disparate network of authorized Licensed Producers of Cannabis. Through its Canada-wide network of care centres, NAC has partnered with health professionals to improve the quality of life of its local members and provide services designed to inform, educate and supply expert advice.
National Access Cannabis Corp. is listed on the TSX Venture Exchange under the symbol (TSXV: NAC).
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements. More particularly, this press release contains forward-looking statements concerning the anticipated benefits of the expansion, the characteristics of the Whyte Avenue property, expected deployment timing, expected operations, traffic volumes, timing of construction, and the possibility and likelihood of future recreational marijuana legislation. The forward-looking statements contained in this document are based on certain key expectations and assumptions made by NAC. Although NAC believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because NAC cannot give any assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks associated with the medical and potential marijuana industry in general.
SOURCE National Access Cannabis Corp.
For further information: National Access Cannabis Corp., Mark Goliger, Chief Executive Officer, 1 (800) 411-1126, Info@NationalAccessCannabis.com; Investor Relations,Robert Kelly, LodeRock Advisors Inc., (416) 992-4539, email@example.com